Sylvie Gomez

Sylvie Gomez is an accomplished project leader with extensive experience in medicinal chemistry and chemoinformatics. Currently serving as a Project Leader at Evotec since September 2019, Sylvie has previously held significant roles such as Team Leader at NovAliX, where leadership encompassed a team of 21 chemists on various projects, and Group Leader at Villapharma Research S.L., overseeing multiple medicinal chemistry projects with substantial collaboration. Prior roles include Head of Chemoinformatics and Chemistry Team Leader at KuDOS Pharmaceuticals, contributing to notable projects like the PARP-1 inhibitor advanced to market as Olaparib, and Laboratory Head at Novartis, managing combinatorial chemistry efforts. Sylvie holds a Ph.D. in Organic Chemistry from the University of Montpellier and an Engineer's Degree in Chemistry from Ecole Nationale superieure de chimie de Montpellier.